Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is soliciting proposals for custom MHC Class II HLA-DP Xynapse and Dextramer reagents aimed at liver cancer neoantigen validation. This opportunity is categorized under product procurement and is not subject to Simplified Acquisition Procedures.
Custom MHC Class II HLA-DP Xynapse and Dextramer Reagents for Liver Cancer Neoantigen Validation
CUSTOM MHC CLASS II HLA-DP XYNAPSE AND DEXTRAMER R is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.